Quality assessment of recent evidence‐based clinical practice guidelines for management of type 2 diabetes mellitus in adults using the AGREE II instrument

• Published in: Journal of evaluation in clinical practice 2018-02, Vol.24 (1), p.166-172
• Main Authors: Anwer, Muhammad A., Al‐Fahed, Ousama B., Arif, Samir I., Amer, Yasser S., Titi, Maher A., Al‐Rukban, Mohammed O.
• Format: Article
• Language: English
• Subjects: AGREE II Instrument; Clinical medicine; Clinical practice guidelines; Diabetes; diabetes mellitus; evaluation; evidence‐based medicine; Quality
• ISSN: 1356-1294; 1365-2753
• DOI: 10.1111/jep.12785

Rationale, aims and objectives Type 2 diabetes mellitus (T2DM) is a worldwide and national public health problem that has a great impact on the population in Saudi Arabia. High‐quality clinical practice guidelines (CPGs) are cornerstones in improving the health care provided for patients with diabetes. This study evaluated the methodological rigour, transparency, and applicability of recently published CPGs. Methods Our group conducted a systematic search for recently published CPGs for T2DM. The searching and screening for Source CPGs were guided by tools from the ADAPTE methods with specific inclusion/exclusion criteria. Five reviewers using the second version of the Appraisal of Guidelines for Research and Evaluation (AGREE II) Instrument independently assessed the quality of the retrieved Source CPGs. Results Domains of Scope and purpose and Clarity of presentation received the highest scores in all CPGs. Most of the assessed CPGs (86%) were considered with high overall quality and were recommended for use. Rigour of development and applicability domains were together highest in 3 CPGs (43%). The overall high quality of DM CPGs published in the last 3 years demonstrated the continuous development and improvement in CPG methodologies and standards. Conclusions Health care professionals should consider the quality of any CPG for T2DM before deciding to use it in their daily clinical practice. Three CPGs have been identified, using the AGREE criteria, as high‐quality and trustworthy. Ideally, the resources provided by the AGREE trust including the AGREE II Instrument should be used by a clinician to scan through the large number of published T2DM CPGs to identify the CPGs with high methodological quality and applicability.